 |
Ben Butkus is senior editor of GenomeWeb's premium content and the editor of PCR Insider. He covers technologies and trends in PCR, qPCR, nucleic acid amplification, and sample prep. E-mail Ben Butkus or follow his GenomeWeb Twitter account at @PCRInsider. |
Studies Show Promise of Inostics' BEAMing Tech to Detect Drug Resistance Markers in Cancer Patients
June 28, 2012
Studies Show Promise of Inostics' BEAMing Tech to Detect Drug Resistance Markers in Cancer Patients
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- As it Readies US Lab, Germany's Inostics Moving Beyond Service Model with Digital PCR Tech
August 18, 2011 / PCR Insider - Dx Focus: BD Max Cdiff; Hologic Aptima HPV; Inostics BEAMing Tech; Veredus Labs VereFlu Test
April 11, 2013 / PCR Insider - Lab21, IntegraGen to Develop PCR-Based Assay to Guide Colorectal Cancer Therapy
February 28, 2013 / PCR Insider - New Players Seek Foothold in Digital PCR Market amid 'Thorny' IP Landscape
July 15, 2010 / PCR Insider - Royalties Drive up GeneNews Q1 Revenues Sharply
May 16, 2013 / GenomeWeb Daily News